Relationship between tumorsize of malignant pleural mesothelioma and its response to chemotherapy

Journal of Health Science

Volumn 53, Issue 1, 2007, Pages 23-30

  Ozden, Hilmi ^a   Ak, Güntülü ^a   Metintas, Selma ^a   Metintas, Muzaffer ^a   Sahin, Bünyamin ^b   Erginel, Sinan ^a   Civi, Kismet ^c  

^a OSMANGAZI UNIVERSITY MEDICAL FACULTY   (Turkey)

^b ONDOKUZ MAYIS UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c DUMLUPINAR UNIVERSITY   (Turkey)

Author keywords

Cavalieri principle; Computed tomography; Malignant mesothelioma; Stereology; Volume estimation

Indexed keywords

ALPHA2A INTERFERON; CISPLATIN; MITOMYCIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MULTIPLE CYCLE TREATMENT; PLEURA MESOTHELIOMA; STANDARD; STEREOLOGY; STEREOMETRY; TREATMENT RESPONSE; TUMOR VOLUME;

EID: 33846858606     PISSN: 13449702     EISSN: 13475207     Source Type: Journal    
DOI: 10.1248/jhs.53.23     Document Type: Article

References (28)

1. Light, R. W. (1995) Pleural Diseases, Lea and Febiger, Philadelphia.
2. Gross-Goupil, M. and Ruffie, P. (1999) Malignant pleural mesotheliom. Bull. Cancer Suppl., 3, 43-54.
3. Chahinian, A. P., Pajak, T. H. and Holland, J. F. (1982) Diffuse malignant mesothelioma. Ann. Intern. Med., 96, 746-755.
4. De Pangher Manzini, V., Brollo, A., Franceschi, S., De Matthaeis, M., Talamini, R. and Bianchi, C. (1993) Prognostic factors of malignant mesothelioma of the pleura. Cancer, 72, 410-417.
5. Hillerdal, G. (1995) Pleural malignancies including mesothelioma. Curr. Opin. Pulm. Med., 1, 339-343.
6. Selçuk, Z. T., Çöplü, L., Emri, S., Kalyoncu, A. F., Sahin, A. A. and Bariş, Y. L. (1992) Malignant pleural mesothelioma due to environmentalmineral fiber exposure in Turkey: analysis of 135 cases. Chest, 102, 790-796.
7. Antman, K. H. (1993) Natural history and epidemiology of malignant mesothelioma. Chest, 103, 373S-376S.
8. Metintaş, M., Metintaş, S., Uçgun I., Gibbs, A. R., Harmanci, E., Alatas, F., Erginel, S., Tel, N. and Pasaoglu, O. (2001) Prognostic factors in diffuse malignant pleural mesothelioma: effects of pretreatment clinical and laboratory characteristics. Respir. Med., 95, 829-835.
9. Metintaş, S., Metintaş, M., Uçgun, I. and Oner, U. (2002) Malignant mesothelioma due to environmental exposure to asbestos. Chest, 122, 2224-2229.
10. Ruffie, P., Lehman, M., Galateau-Salle, F., Lagrange, J. L. and Pairon, J. C. (1998) Standards, options, and recommendations for the menagement of patients with malignant mesothelioma of the pleura. Bull. Cancer, 85, 545-561.
11. Vogelzang, N. J. (1992) Malignant mesothelioma: diagnostic and management strategies for 1992. Semin. Oncol., 19, 64-71.
12. Metintaş, M., Özdemir, N., Uçgun, I., Elbek, O., Kolsuz, M., Mutlu, S. and Metintaş, S. (1999) Cisplatin, mitomycin, and interferon α2a combination chemoimmunotherapy in the treatment of diffuse malignant pleural mesothelioma. Chest, 116, 391-398.
13. Byrne, M. J. and Nowak, A. K. (2004) Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann. Oncol., 15, 257-260.
14. Monetti, F., Casanova, S., Grasso, A., Cafferata, M. A., Ardizzoni, A. and Neumaier, C. E. (2004) Inadequacy of the new Response Evaluation Criteria in solid tumors (RECIST) in patients with malignant pleural mesothelioma: report of four cases. Lung Cancer, 43, 71-74.
15. Rusch, V. W. (1995) A proposed new international TNMstaging system for malignant pleural mesothelioma. Chest, 108, 1122-1129.
16. Pass, H. I., Temeck, B. K., Kranda, K., Steinberg, S. M. and Feuerstein, I. R. (1998) Preoperative tumor volume is associated with outcome in malignant pleural mesothelioma. J. Thorac. Cardiovasc. Surg., 115, 310-318.
17. Sahin, B., Emirzeoglu, M., Uzun, A., Incesu, L., Bek, Y., Bilgic, S. and Kaplan, S. (2003) Unbiased estimation of the liver volume by the Cavalieri principle using magnetic resonance images. Eir. J. Radiol, 47, 164-170.
18. Roberts, N., Cruz-Orive, L. M., Reid, N. M. K., Brodie, D. A., Bourne, M. and Edwards, R. H. (1993) Unbiased estimation of human body composition by the Cavalieri method using magnetic resonance imaging. J. Microsc., 171, 239-253.
19. Gundersen, H. J. G., Boysen, M. and Reith, A. (1981) Comparison of semiautomatic digitizer-tablet and simple point counting performance in morphometry. Virchows Arch. B. Cell. Pathol. Incl. Mol. Pathol., 37, 317-325.
20. Odaci, E., Sahin, B., Sönmez, O. F., Kaplan, S., Bas, O., Bilgic, S., Bek, Y. and Ergur, H. (2003) Rapid estimation of the vertebral body volume: a combination of the Cavalieri principle and computed tomography images. Eir. J. Radiol, 48, 316-326.
21. Gundersen, H. J. G. and Jensen, E. B. (1987) The efficiency of systematic sampling in stereology and its prediction. J. Microsc., 147, 229-263.
22. Reid, M. H. (1983) Organ and lesion volume measurements with computed tomography. J. Comput. Assist. Tomogr., 7, 268-273.
23. Riffenburg, R. H. (1999) Statistics in Medicine, Academic Press, San Diego.
24. Metintaş, M., Uçgun, İ., Elbek, O. Erginel, S., Metintaş, S., Kolsuz, M., Harmanci, E., Alataş, F., Hillerdal, G., Özkan, R. and Kaya, T. (2002) Computed tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases. Eir. J. Radiol, 41, 1-9.
25. Kawashima, A. and Libshitz, H. I. (1990) Malignant pleural mesothelioma: CT manifestations in 50 cases. Am. J. Roentgenol., 155, 965-969.
26. Mirvis, S., Dutcher, J. P., Haney, P. J., Whitley, N. O. and Aisner, J. (1983) CT of malignant pleural mesothelioma. Am. J. Roentgenol., 140, 665-670.
27. Yörükoǧlu, K., Sayhan, S. and Dicle, N. (2001) Tumor volume estimation by the percentage carcinoma method in uterine cervix carcinoma. Analyt. Quant. Cytol. Histol., 23, 89-92.
28. Mayr, N. A., Yuh, W. T. C., Zheng, J., Ehrhardt J. C., Sorosky, J. I., Magnotta, V. A., Pelsang, R. E. and Hussey, D. H. (1997) Tumor size evaluated by pelvic examination compared with 3-D MR quantitative analysis in the prediction of outcome for cervical cancer. Int. J. Radiat. Oncol. Biol. Phys., 39, 395-404.